WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 PRESS RELEASE DATED FEBRUARY 6, 2009 2]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 PRESS RELEASE DATED FEBRUARY 6, 2009 2]
CSUN [China Sunergy] 6-K: (Original Filing)
[China Sunergy Co., Ltd. Ruennsheng Allen Wang Chief Executive Officer 2]
CSUN [China Sunergy] 6-K: China Sunergy Co., Ltd. Ruennsheng Allen Wang Chief
[China Sunergy Co., Ltd. Ruennsheng Allen Wang Chief Executive Officer 2]
GSOL [GLOBAL SOURCES] SC 13D/A: (Original Filing)
[CUSIP No. G39300 10 1 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY]
GSOL [GLOBAL SOURCES] SC 13D/A: CUSIP No. G39300 10 1 1 NAMES OF
[CUSIP No. G39300 10 1 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) o (b) 3 SEC USE ONLY]
KZ [KONGZHONG] SC 13G/A: (Original Filing)
[CUSIP No. 50047P104 1. Names of Reporting Persons IDG-Accel China Growth Fund II L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) o (a) o]
KZ [KONGZHONG] SC 13G/A: CUSIP No. 50047P104 1. Names of Reporting Persons
[CUSIP No. 50047P104 1. Names of Reporting Persons IDG-Accel China Growth Fund II L.P. 2. Check the Appropriate Box if a Member of a Group (See Instructions) o (a) o]
SIMO [Silicon Motion Technology] 6-K: (Original Filing)
[Silicon Motion Announces Fourth Quarter Results for the Period Ended December 31, 2008 Fourth Quarter 2008 Financial Highlights * Net sales decreased 28% quarter-over-quarter to US$32.3 million * Gross margin excluding stock-based compensation was flat at 50.3% compared with 3Q08 * Operating expenses excluding stock-based compensation, acquisition-related charges, and one-time items decreased from US$14.1 million in 3Q08 to US$12.2 million] [Press Release issued by the Company on February 5, 2009. 2 ILICON OTION ECHNOLOGY ORPORATION S]
